Patent US4061645A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4061645A Expired / Lapsed US ⏱️ 0.0 years remaining

2-Trichloromethyl-5-methylsulfinyl-1,3,4-thiadiazole

Assignee: Bayer Pharma AG
•
Filing: 1972-10-17
•
Granted: 1977-12-06
•
Expires: 1992-10-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New 1,3,4-thiadiazoles substituted in the 2 and 5 positions for use as soil and seed fungicides, nematocides and the processes therefor.

Inventors

  • 👤 Ludwig Nusslein
  • 👤 Ernst Albrecht Pieroh
  • 👤 Kurt Roder

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 05:28
CPC Classifications
C; C07; C07D; C07D285/00; C07D285/01; C07D285/02; C07D285/04; C07D285/12; C07D285/125; A; A01; A01N; A01N43/00; A01N43/72; A01N43/82

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 3 words
The compound 2-trichloromethyl-5-methylsulfinyl-1,3,4-thiadiazol.
Claim 2
Dependent Claim 3 words
The compound 2-trichloromethyl-5-methylsulfinyl-1,3,4-thiadiazol.

References Cited (Backward Citations)

US3562284A Cited
US3692794A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-12-05 1981-06-06 1981-12-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-12-05 1985-06-06 1985-12-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-12-05 1989-06-06 1989-12-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag